Final results of a phase II randomized trial of neoadjuvant anthracycline-taxane chemotherapy plus lapatinib, trastuzumab, or both in HER2-positive breast cancer (CHER-LOB trial).
Valentina Guarneri(Istituto Oncologico Veneto), PierFranco Conte(University of Padua), Fabrizio Artioli(Roche (Switzerland)), Roberto D’Amico(University of Modena and Reggio Emilia), Daniele Generali(University of Trieste), Alberto Bottini(University of Genoa), Alessandra Ravaioli(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Giovanni Giardina(Istituti Ospitalieri di Cremona), C. Boni(Ospedale Santa Maria), Giancarlo Bisagni, Antonino Musolino(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Antonio Frassoldati(Italian Oncology Group of Clinical Research), Luigi Cavanna(University of Pavia), Enrico Tagliafico(University of Modena and Reggio Emilia), Federico Piacentini(Azienda Unita' Sanitaria Locale Di Modena), Laura Orlando, Michael Untch(Helios Kliniken), D. Amadori(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), M. Bagnalasta(GlaxoSmithKline (Netherlands))
Cited by 32
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
|Journal of Clinical Oncology|2000|3.8k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
|Journal of Clinical Oncology|2000|2.3k
Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.
|IRIS UNIMORE (University of Modena and Reggio Emilia)|2005|1.6k